Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
TERN-601 by Terns Pharmaceuticals for Obesity: Likelihood of Approval
TERN-601 is under clinical development by Terns Pharmaceuticals and currently in Phase I for Obesity. According to GlobalData, Phase I...